Stocks Explorer
Stocks
Sectors
Search
Basilea Pharmaceutica AG(0QNA) News
Profile
Chart
News
Analysis
0QNA price today
by TradingView
Date
Title
Apr 9
Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics
Jan 15
Basilea announces acquisition of preclinical antibiotics program from Spexis
‹ Prev
Page
of 1
Next ›